CDK9 inhibitors selectively target estrogen receptor-positive breast cancer cells through combined inhibition of<i>MYB</i>and<i>MCL-1</i>expressionPartha Mitra, Thomas J. Gonda|Oncotarget|2016Cited by 44
The mechanism of MYB transcriptional regulation by MLL-AF9 oncoproteinLu Cao, Thomas J. Gonda|Scientific Reports|2019Cited by 10